Delivery Order SPE2DB22D2006-SPE2DB24FW2EG

Award Date 7/24/24
Potential Completion Date 8/14/24
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of XEOMIN 100 unit vials. The contract has a ceiling value of $1,310.60 and is a firm-fixed-price delivery order with an ultimate completion date of August 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the delivery of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials. The award, valued at $12,582, has a firm fixed-price contract type and an ultimate completion date of September 19, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The IDC enables the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The contract has a firm fixed price, with a ceiling value of $2,793.70, and a performance period ending on June 25, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 200 UNIT VIALS, with a ceiling value of $8,381.10 and a completion date of July 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $18,873.00, is for the delivery of 4,566,181,768 units of XEOMIN 200 unit vials. The contract has a Firm Fixed Price pricing type and a period of performance through November 13, 2024. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract provides for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, with a ceiling value of $31,454.40 and a performance period ending on May 14, 2024. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The contract has a firm fixed price of $11,174.80 and a performance period through May 13, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the procurement of XEOMIN 200 unit vials. The contract is a firm-fixed price type with a ceiling value of $9,436.50 and has an ultimate completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside for any specific business category. The contract is part of a larger indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, for the supply of XEOMIN 50 UNIT VIALS. The contract has a ceiling value of $8,550.00 and a period of performance through August 26, 2024. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to...
This is a $9,174.30 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XEOMIN 200 unit vials, a pharmaceutical product, with a completion date of August 8, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2EG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XEOMIN 200 unit vials. The award has a ceiling value of $9,436.50 and is a firm fixed price contract. The period of performance extends through August 14, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. No set-aside designation is provided for this specific award.

Generated 10/23/24, 9:22 AM